Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

GE HealthCare Technologies Inc. (GEHC) had Revenue of $19.67B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$19.67B
Net Income	$1.99B
Cost of Goods Sold	$11.47B
Gross Profit	$8.21B
Operating Expenses	$17.05B
Operating Income	$2.62B
Non-Operating Income/Expense	$-43.00M
Pre-Tax Income	$2.58B
Normalized Pre-Tax Income	$2.58B
Income after Taxes	$2.05B
Income from Continuous Operations	$2.05B
Consolidated Net Income/Loss	$2.05B
Normalized Income after Taxes	$2.05B
EBIT	$2.62B
EBITDA	$3.21B
Weighted-Average Shares Outstanding (Basic)	456.00M
Weighted-Average Shares Outstanding (Diluted)	459.00M
Earnings per Share (EPS) (Basic)	$4.37
Earnings per Share (EPS) (Diluted)	$4.34
Balance Sheet Financials
Current Assets	$9.90B
Property, Plant, and Equipment	$2.55B
Long-Term Assets	$23.19B
Total Assets	$33.09B
Current Liabilities	$9.55B
Long-Term Debt	$7.45B
Long-Term Liabilities	$15.07B
Total Liabilities	$24.62B
Common Equity	$8.46B
Tangible Shareholders Equity	$-5.75B
Shareholders Equity	$8.46B
Common Shares Outstanding	456.96M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.96B
Cash Flow from Investing Activities	$-914.00M
Cash Flow from Financial Activities	$-573.00M
Beginning Cash	$2.51B
End Cash	$2.89B
Increase/Decrease in Cash	$387.00M
Stock-Based Compensation	$125.00M
Common Stock Dividends Paid	$-55.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.04
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.47
Debt to Equity Ratio	1.24
Gross Margin	41.71%
Operating Margin	13.34%
EBIT Margin	13.34%
EBITDA Margin	16.29%
Pre-Tax Profit Margin	13.12%
Profit Margin	10.13%
Free Cash Flow	$1.55B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.59
Inventory Turnover	5.91
Receiveable Turnover	5.51
Days Sales in Receivables	66.22
Return on Equity	24.22%
Return on Tangible Equity	-35.65%
Return on Assets	6.20%
Return on Investments	12.88%
Book Value Per Share	$18.52
Free Cash Flow per Share	$3.39
Operating Cash Flow per Share	$4.26

Data from Zacks Investment Research, Inc.